Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

China · Delayed Price · Currency is CNY

40.40

+1.66 (4.28%)

At close: Jul 1, 2026

33.73% (1Y)

Market Cap	3.95B +38.0%
Revenue (ttm)	412.52M -5.9%
Net Income	85.70M -18.5%
EPS	0.88 -18.2%
Shares Out	97.81M
PE Ratio	46.11
Forward PE	n/a
Dividend	0.80 (2.07%)
Ex-Dividend Date	May 26, 2026

Volume	2,178,838
Open	39.17
Previous Close	38.74
Day's Range	38.35 - 41.35
52-Week Range	29.37 - 61.22
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688273

Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation and anti-aging product, and sports rehabilitation products, as well as consumables and IT products, such as vaginal electrodes, rectal electrodes, and vaginal probes. The company also provides electronic colposcopes, biofeedback stimulation de... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2013

Employees 550

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688273

Full Company Profile

Financial Performance

In 2025, SHA:688273's revenue was 431.59 million, an increase of 1.66% compared to the previous year's 424.55 million. Earnings were 102.63 million, an increase of 1.03%.

Financial Statements